168 related articles for article (PubMed ID: 37794456)
21. Relationship between estimated glomerular filtration rate and incident cardiovascular disease in an ethnically diverse primary care cohort.
Church E; Poppe K; Harwood M; Mehta S; Grey C; Selak V; Marshall MR; Wells S
N Z Med J; 2019 Mar; 132(1491):11-26. PubMed ID: 30845125
[TBL] [Abstract][Full Text] [Related]
22. Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes.
Perkins BA; Bebu I; Gao X; Karger AB; Hirsch IB; Karanchi H; Molitch ME; Zinman B; Lachin JM; de Boer IH
Diabetes Care; 2022 Mar; 45(3):585-593. PubMed ID: 35015817
[TBL] [Abstract][Full Text] [Related]
23. Glomerular filtration function decline, mortality, and cardiovascular events: data from the Strong Heart Study.
Suchy-Dicey AM; Zhang Y; McPherson S; Tuttle KR; Howard BV; Umans J; Buchwald DS
Kidney360; 2021 Jan; 2(1):71-78. PubMed ID: 33954294
[TBL] [Abstract][Full Text] [Related]
24. eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m
Sugawara Y; Kanda E; Ohsugi M; Ueki K; Kashihara N; Nangaku M
Clin Exp Nephrol; 2024 Feb; 28(2):144-152. PubMed ID: 37806976
[TBL] [Abstract][Full Text] [Related]
25. Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study.
Hosseinpanah F; Barzin M; Golkashani HA; Nassiri AA; Sheikholeslami F; Azizi F
BMC Nephrol; 2012 Jul; 13():59. PubMed ID: 22799559
[TBL] [Abstract][Full Text] [Related]
26. The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.
Canney M; Gunning HM; Zheng Y; Rose C; Jauhal A; Hur SA; Sahota A; Reich HN; Barbour SJ
Am J Kidney Dis; 2022 Dec; 80(6):740-750. PubMed ID: 35659570
[TBL] [Abstract][Full Text] [Related]
27. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
[TBL] [Abstract][Full Text] [Related]
28. Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes.
Ragot S; Saulnier PJ; Velho G; Gand E; de Hauteclocque A; Slaoui Y; Potier L; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Fumeron F; Roussel R; Marre M; Hadjadj S;
Diabetes Care; 2016 Jul; 39(7):1259-66. PubMed ID: 27222502
[TBL] [Abstract][Full Text] [Related]
29. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
[TBL] [Abstract][Full Text] [Related]
30. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
Al-Shamsi S; Regmi D; Govender RD
BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
[TBL] [Abstract][Full Text] [Related]
31. Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study.
Zhang L; Hauske S; Ono Y; Kyaw MH; Steubl D; Naito Y; Kanasaki K
BMJ Open; 2022 Feb; 12(2):e052246. PubMed ID: 35197338
[TBL] [Abstract][Full Text] [Related]
32. Parental history of premature cardiovascular disease, estimated GFR, and rate of estimated GFR decline: results from the Aerobics Center Longitudinal Study.
Huang X; Sui X; Ruiz JR; Hirth V; Ortega FB; Blair SN; Carrero JJ
Am J Kidney Dis; 2015 May; 65(5):692-700. PubMed ID: 25600488
[TBL] [Abstract][Full Text] [Related]
33. Magnitude of rate of change in kidney function and future risk of cardiovascular events.
Turin TC; Jun M; James MT; Tonelli M; Coresh J; Manns BJ; Hemmelgarn BR
Int J Cardiol; 2016 Jan; 202():657-65. PubMed ID: 26453813
[TBL] [Abstract][Full Text] [Related]
34. Accounting for the Competing Risk of Death to Predict Kidney Failure in Adults With Stage 4 Chronic Kidney Disease.
Al-Wahsh H; Tangri N; Quinn R; Liu P; Ferguson Ms T; Fiocco M; Lam Md MSc NN; Tonelli M; Ravani P
JAMA Netw Open; 2021 May; 4(5):e219225. PubMed ID: 33944922
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Prediction Model for Future Estimated Glomerular Filtration Rate in People With Type 2 Diabetes and Chronic Kidney Disease.
Gregorich M; Kammer M; Heinzel A; Böger C; Eckardt KU; Heerspink HL; Jung B; Mayer G; Meiselbach H; Schmid M; Schultheiss UT; Heinze G; Oberbauer R;
JAMA Netw Open; 2023 Apr; 6(4):e231870. PubMed ID: 37017968
[TBL] [Abstract][Full Text] [Related]
36. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
37. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
38. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.
Lim CC; Teo BW; Ong PG; Cheung CY; Lim SC; Chow KY; Meng CC; Lee J; Tai ES; Wong TY; Sabanayagam C
Eur J Prev Cardiol; 2015 Aug; 22(8):1018-26. PubMed ID: 24857889
[TBL] [Abstract][Full Text] [Related]
39. The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies.
Deravi N; Sharifi Y; Koohi F; Zadeh SST; Masrouri S; Azizi F; Hadaegh F
BMC Public Health; 2023 Mar; 23(1):565. PubMed ID: 36973769
[TBL] [Abstract][Full Text] [Related]
40. Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial).
Malhotra R; Katz R; Jotwani V; Agarwal A; Cohen DL; Cushman WC; Ishani A; Killeen AA; Kitzman DW; Oparil S; Papademetriou V; Parikh CR; Raphael KL; Rocco MV; Tamariz LJ; Whelton PK; Wright JT; Shlipak MG; Ix JH
Am J Kidney Dis; 2021 Jul; 78(1):48-56. PubMed ID: 33333147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
